{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:05:53Z","timestamp":1791356753613,"version":"4.3.1"},"reference-count":50,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Internet Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non\u2013small cell lung cancer (NSCLC) remains the leading cause of cancer-related mortality worldwide. Accurate early prediction of response to neoadjuvant therapy is critical.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We aimed to evaluate the diagnostic performance of radiomics-based AI in predicting pathological complete response (pCR) and major pathological response (MPR) following neoadjuvant immunochemotherapy in NSCLC and to compare it against traditional radiological criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search of PubMed, Embase, Cochrane Library, and Web of Science was conducted through October 26, 2025. Studies utilizing computed tomography (CT) or positron emission tomography\/CT-based AI models to predict pCR or MPR were included. Methodological quality was appraised using the PROBAST (Prediction Model Risk of Bias Assessment Tool)+AI tool. Sensitivity, specificity, and area under the curve (AUC) were pooled using a bivariate random effects model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty-three studies involving 2004 patients in validation sets were included, with histopathology as the gold standard. For pCR, AI models achieved a pooled sensitivity of 0.77 (95% CI 0.70\u20100.83), specificity of 0.79 (95% CI 0.73\u20100.84), and AUC of 0.85, significantly outperforming traditional criteria in sensitivity (0.77 vs 0.42;\n                      <jats:italic>P<\/jats:italic>\n                      &lt;.001). For MPR, AI demonstrated a sensitivity of 0.80 (95% CI 0.72\u20100.87), specificity of 0.83 (95% CI 0.73\u20100.90), and AUC of 0.88, also superior to traditional models (AUC: 0.88 vs 0.65,\n                      <jats:italic>P<\/jats:italic>\n                      &lt;.001). Subgroup analysis revealed that positron emission tomography\/CT-based models offered higher specificity for MPR than CT-based models (0.95 vs 0.80,\n                      <jats:italic>P<\/jats:italic>\n                      =.005).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Radiomics-based AI demonstrates high diagnostic accuracy and superior sensitivity compared to traditional radiological criteria, showing significant potential for preoperative response assessment. However, the heterogeneity and retrospective design of current studies limit the evidence. Future large-scale, prospective, multicenter trials and multimodal data integration are required to validate these findings for clinical translation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/93892","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T04:11:30Z","timestamp":1786680690000},"page":"e93892-e93892","source":"Crossref","is-referenced-by-count":3,"title":["Radiomics-Based AI for Predicting Neoadjuvant Immunochemotherapy Pathological Response in Non\u2013Small Cell Lung Cancer: Systematic Review and Meta-Analysis"],"prefix":"10.2196","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5197-6317","authenticated-orcid":false,"given":"Ziqi","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2274-0897","authenticated-orcid":false,"given":"Yuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9308-1494","authenticated-orcid":false,"given":"Shuyu","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4188-9638","authenticated-orcid":false,"given":"Hongsheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"issue":"3","key":"R1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.21037\/tlcr.2016.06.07","article-title":"Non-small cell lung cancer: current treatment and future advances","volume":"5","author":"Zappa","journal-title":"Transl Lung Cancer Res"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1115156","article-title":"Different pathological response and histological features following neoadjuvant chemotherapy or chemo-immunotherapy in resected non-small cell lung cancer","volume":"13","author":"Al\u00ec","journal-title":"Front Oncol"},{"issue":"11","key":"R3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14112775","article-title":"Pathological response and immune biomarker assessment in non-small-cell lung carcinoma receiving neoadjuvant immune checkpoint inhibitors","volume":"14","author":"Rojas","journal-title":"Cancers (Basel)"},{"issue":"6","key":"R4","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11061041","article-title":"Imaging assessment of tumor response in the era of immunotherapy","volume":"11","author":"Nakata","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"R5","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-011773","article-title":"NeoPred: dual-phase CT AI forecasts pathologic response to neoadjuvant chemo-immunotherapy in NSCLC","volume":"13","author":"Zheng","journal-title":"J Immunother Cancer"},{"issue":"1","key":"R6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s00259-025-07350-8","article-title":"Multi-Organ metabolic profiling with [F]F-FDG PET\/CT predicts pathological response to neoadjuvant immunochemotherapy in resectable NSCLC","volume":"53","author":"Ma","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"R7","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s40336-025-00734-8","article-title":"Prognostic value of 18 F-FDG PET\/CT radiomics for survival and recurrence in non\u2013small cell lung cancer: a systematic review of 3,180 patients","volume":"13","author":"Elhaie","journal-title":"Clin Transl Imaging"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1007\/s13193-025-02469-4","article-title":"Predicting neoadjuvant chemotherapy response in breast cancer using multiparametric MRI-based radiomics and machine learning: a systematic review and meta-analysis of 1,469 patients","author":"Elhaie","journal-title":"Indian J Surg Oncol"},{"issue":"4","key":"R9","doi-asserted-by":"publisher","first-page":"662","DOI":"10.18502\/fbt.v11i4.16515","article-title":"Advancing oncology through imaging: evaluating FDG-PET\u2019s role in cancer diagnosis and staging","volume":"11","author":"Elhaie","journal-title":"Front Biomed Technol"},{"issue":"10","key":"R10","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.1097\/JS9.0000000000002821","article-title":"Multichannel deep learning prediction of major pathological response after neoadjuvant immunochemotherapy in lung cancer: a multicenter diagnostic study","volume":"111","author":"Geng","journal-title":"Int J Surg"},{"issue":"10","key":"R11","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-012526","article-title":"Attention-guided framework for integrative omics and temporal dynamics in predicting major pathological response in neoadjuvant immunochemotherapy for NSCLC","volume":"13","author":"Gan","journal-title":"J Immunother Cancer"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2025.112171","article-title":"Non-invasive CT based multiregional radiomics for predicting pathologic complete response to preoperative neoadjuvant chemoimmunotherapy in non-small cell lung cancer","volume":"189","author":"Fan","journal-title":"Eur J Radiol"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m2632","article-title":"Preferred Reporting Items for Systematic Review and Meta-Analysis of Diagnostic Test Accuracy Studies (PRISMA-DTA): explanation, elaboration, and checklist","volume":"370","author":"Salameh","journal-title":"BMJ"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-082505","article-title":"PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods","volume":"388","author":"Moons","journal-title":"BMJ"},{"issue":"7","key":"R15","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.jclinepi.2014.01.006","article-title":"Applying Grading of Recommendations Assessment, Development and Evaluation (GRADE) to diagnostic tests was challenging but doable","volume":"67","author":"Gopalakrishna","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"R16","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1177\/0272989X08319957","article-title":"Bivariate random effects meta-analysis of ROC curves","volume":"28","author":"Arends","journal-title":"Med Decis Making"},{"issue":"11","key":"R17","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","journal-title":"Stat Med"},{"issue":"9","key":"R18","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jclinepi.2005.01.016","article-title":"The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed","volume":"58","author":"Deeks","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"R19","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-025-04017-z","article-title":"Multicenter evaluation of predictive clinical and imaging factors for pathological response in non-small cell lung cancer patients treated with neoadjuvant chemotherapy and immune checkpoint inhibitors","volume":"74","author":"Zhang","journal-title":"Cancer Immunol Immunother"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1414954","article-title":"CT-based quantification of intratumoral heterogeneity for predicting pathologic complete response to neoadjuvant immunochemotherapy in non-small cell lung cancer","volume":"15","author":"Ye","journal-title":"Front Immunol"},{"issue":"9","key":"R21","doi-asserted-by":"publisher","first-page":"39231545","DOI":"10.1136\/jitc-2024-009348","article-title":"Non-invasive multimodal CT deep learning biomarker to predict pathological complete response of non-small cell lung cancer following neoadjuvant immunochemotherapy: a multicenter study","volume":"12","author":"Ye","journal-title":"J Immunother Cancer"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103551","article-title":"AI-derived longitudinal and multi-dimensional CT classifier for non-small cell lung cancer to optimize neoadjuvant chemoimmunotherapy decision: a multicentre retrospective study","volume":"89","author":"Ye","journal-title":"EClinicalMedicine"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bspc.2024.106800","article-title":"A2ST-GCM: an adaptive spatio-temporal aware graph convolutional model for predicting pathological complete response in neoadjuvant therapy","volume":"99","author":"Yang","journal-title":"Biomed Signal Process Control"},{"issue":"28","key":"R24","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1111\/1759-7714.15052","article-title":"Predicting pathological response to neoadjuvant or conversion chemoimmunotherapy in stage IB-III non-small cell lung cancer patients using radiomic features","volume":"14","author":"Yang","journal-title":"Thorac Cancer"},{"issue":"7","key":"R25","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1007\/s00330-023-10503-8","article-title":"[18F]FDG PET-CT radiomics signature to predict pathological complete response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer: a multicenter study","volume":"34","author":"Yang","journal-title":"Eur Radiol"},{"issue":"9","key":"R26","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.21037\/tlcr-2025-259","article-title":"Tumor rim-specific computed tomography radiomics improves prediction of pathological complete response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer","volume":"14","author":"Yang","journal-title":"Transl Lung Cancer Res"},{"issue":"5","key":"R27","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezaf132","article-title":"Machine learning algorithms integrating positron emission tomography\/computed tomography features to predict pathological complete response after neoadjuvant chemoimmunotherapy in lung cancer","volume":"67","author":"Sheng","journal-title":"Eur J Cardiothorac Surg"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1327779","article-title":"Non-invasive prediction for pathologic complete response to neoadjuvant chemoimmunotherapy in lung cancer using CT-based deep learning: a multicenter study","volume":"15","author":"Qu","journal-title":"Front Immunol"},{"issue":"3","key":"R29","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.14336\/AD.2024.0169","article-title":"Deep learning based on computed tomography predicts response to chemoimmunotherapy in lung squamous cell carcinoma","volume":"16","author":"Peng","journal-title":"Aging Dis"},{"issue":"1","key":"R30","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-13905-7","article-title":"Prediction of pathological complete response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer using F-FDG PET radiomics features of primary tumour and lymph nodes","volume":"25","author":"Liu","journal-title":"BMC Cancer"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1425837","article-title":"Radiomics based on F-FDG PET\/CT for prediction of pathological complete response to neoadjuvant therapy in non-small cell lung cancer","volume":"14","author":"Liu","journal-title":"Front Oncol"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1115291","article-title":"Development and validation of a radiomics-based nomogram for predicting a major pathological response to neoadjuvant immunochemotherapy for patients with potentially resectable non-small cell lung cancer","volume":"14","author":"Liu","journal-title":"Front Immunol"},{"issue":"4","key":"R33","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1007\/s00330-023-10241-x","article-title":"Delta-radiomics features for predicting the major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer","volume":"34","author":"Han","journal-title":"Eur Radiol"},{"issue":"4","key":"R34","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.21037\/tlcr-2024-1131","article-title":"Integrative radiomics analysis of peri-tumoral and habitat zones for predicting major pathological response to neoadjuvant immunotherapy and chemotherapy in non-small cell lung cancer","volume":"14","author":"Han","journal-title":"Transl Lung Cancer Res"},{"issue":"13","key":"R35","doi-asserted-by":"publisher","first-page":"4806","DOI":"10.1007\/s00259-025-07342-8","article-title":"Quantitative F-FDG PET\/CT model for predicting pathological complete response to neoadjuvant immunochemotherapy in NSCLC: comparison with RECIST 1.1 and PERCIST","volume":"52","author":"Deng","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"R36","doi-asserted-by":"publisher","first-page":"6052","DOI":"10.1007\/s00330-025-11563-8","article-title":"Short-term intra- and peri-tumoral spatiotemporal CT radiomics for predicting major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer","volume":"35","author":"Bao","journal-title":"Eur Radiol"},{"issue":"4","key":"R37","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s11547-024-01796-w","article-title":"Image-based artificial intelligence for the prediction of pathological complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer: a systematic review and meta-analysis","volume":"129","author":"Shen","journal-title":"Radiol Med"},{"issue":"2","key":"R38","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00330-020-07141-9","article-title":"Radiomics in predicting treatment response in non-small-cell lung cancer: current status, challenges and future perspectives","volume":"31","author":"Chetan","journal-title":"Eur Radiol"},{"issue":"7","key":"R39","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.21037\/tlcr-23-5","article-title":"Review of the use of radiomics to assess the risk of recurrence in early-stage non-small cell lung cancer","volume":"12","author":"Libling","journal-title":"Transl Lung Cancer Res"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1026216","article-title":"Artificial intelligence with magnetic resonance imaging for prediction of pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer: a systematic review and meta-analysis","volume":"12","author":"Jia","journal-title":"Front Oncol"},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2022.110247","article-title":"Machine learning with magnetic resonance imaging for prediction of response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis","volume":"150","author":"Liang","journal-title":"Eur J Radiol"},{"issue":"8","key":"R42","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.3390\/cancers15082297","article-title":"Radiomics of tumor heterogeneity in F-FDG-PET-CT for predicting response to immune checkpoint inhibition in therapy-na\u00efve patients with advanced non-small-cell lung cancer","volume":"15","author":"Ventura","journal-title":"Cancers (Basel)"},{"issue":"4","key":"R43","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040814","article-title":"FDG-PET radiomics for response monitoring in non-small-cell lung cancer treated with radiation therapy","volume":"13","author":"Carles","journal-title":"Cancers (Basel)"},{"issue":"1","key":"R44","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-04904-6","article-title":"A novel sub-regional radiomics model to predict immunotherapy response in non-small cell lung carcinoma","volume":"22","author":"Peng","journal-title":"J Transl Med"},{"key":"R45","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1348678","article-title":"Radiomics model based on intratumoral and peritumoral features for predicting major pathological response in non-small cell lung cancer receiving neoadjuvant immunochemotherapy","volume":"14","author":"Huang","journal-title":"Front Oncol"},{"issue":"7","key":"R46","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/tomography11070078","article-title":"Deep learning approaches for automated prediction of treatment response in non-small-cell lung cancer patients based on CT and PET imaging","volume":"11","author":"Guzm\u00e1n G\u00f3mez","journal-title":"Tomography"},{"issue":"8056","key":"R47","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/s41586-025-08675-y","article-title":"Multimodal generative AI for medical image interpretation","volume":"639","author":"Rao","journal-title":"Nature"},{"issue":"1","key":"R48","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02243-6","article-title":"Advances in molecular pathology and therapy of non-small cell lung cancer","volume":"10","author":"Huang","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"R49","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.240982","article-title":"Navigating the AI landscape in medical imaging: a critical analysis of technologies, implementation, and implications","volume":"315","author":"Sosna","journal-title":"Radiology"},{"key":"R50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2023.111159","article-title":"A scoping review of interpretability and explainability concerning artificial intelligence methods in medical imaging","volume":"169","author":"Champendal","journal-title":"Eur J Radiol"}],"container-title":["Journal of Medical Internet Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:01:41Z","timestamp":1791313301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmir.org\/2026\/1\/e93892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":50,"URL":"https:\/\/doi.org\/10.2196\/93892","relation":{},"ISSN":["1438-8871"],"issn-type":[{"value":"1438-8871","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"article-number":"v28i3e93892"}}